SM

Sushil Machan

Active Director Director DIN 08880778
DIN 08880778 First appointment Sep 2020 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Sushil Machan

Data last updated:

Sushil Machan is a Director at Fitndiet Pharmaceuticals Private Limited (since 2020). The company operates in Chemicals.

DIN 08880778
Primary Designation Director
Industry Chemicals
First Appointment 16 Sep 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Sep 20202020Active

Board colleagues of Sushil Machan

Directorship timeline

Open interactive timeline →
Fitndiet Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sushil Machan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sushil Machan

Sushil Machan currently holds 1 directorship: Fitndiet Pharmaceuticals Private Limited (Director, since 16 Sep 2020).

Sushil Machan was first appointed on 16 Sep 2020 as Director at Fitndiet Pharmaceuticals Private Limited.

The current boards of Sushil Machan's companies include Kamaldeep Kumar Bassi (Fitndiet Pharmaceuticals Private Limited), Pawan Kumar (Fitndiet Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available